BioCryst Awarded BCX4430 Advanced Development Contract

March 31, 2015 10:59 AM

8 0

BARDA Awards NDA Enabling CMC & Non-Clinical Toxicology Studies Contract for BCX4430

RESEARCH TRIANGLE PARK, N.C., March 31, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services'Office of the Assistant Secretary for Prepared...

Also read: Top U.S. Officials Met With Defiance in Visit to Mexico

Read more

To category page